Establishment and Characterization of MTDH Knockdown by Artificial Micro RNA Interference - Functions as a Potential Tumor Suppressor in Breast Cancer

  • Wang, Song (Department of Oncosurgery, Affiliated Nanhua Hospital) ;
  • Shu, Jie-Zhi (Department of Oncosurgery, Affiliated Nanhua Hospital) ;
  • Cai, Yi (Department of Oncosurgery, Affiliated Nanhua Hospital) ;
  • Bao, Zheng (Department of Oncosurgery, Affiliated Nanhua Hospital) ;
  • Liang, Qing-Mo (Department of Oncosurgery, Affiliated Nanhua Hospital)
  • Published : 2012.06.30


Background: Considerable evidence suggests that metadherin (MTDH) is a potentially crucial mediator of tumor malignancy and an important therapeutic target for simultaneously enhancing chemotherapy efficacy and reducing metastasis risk. Inhibition of MTDH expression by RNA interference has been shown in several previous research, but silencing MTDH expression by microRNA (miRNA) interference in breast cancer has not been established. In the present study, we investigated the role of MTDH-miRNA in down-regulation of proliferation, motility and migration of breast carcinoma cells. Methods: Expression vectors of recombinant plasmids expressing artificial MTDH miRNA were constructed and transfected to knockdown MTDH expression in MDA-MB-231 breast cancer cells. Expression of MTDH mRNA and protein was detected by RT-PCR and Western blot, respectively. MTT assays were conducted to determine proliferation, and wound healing assays and transwell migration experiments for cell motility and migration. Results: Transfection of recombinant a plasmid of pcDNA-MTDH-miR-4 significantly suppressed the MTDH mRNA and protein levels more than 69% in MDA-MB-231 breast cancer cells. This knockdown significantly inhibited proliferation, motility and migration as compared with controls. Conclusions: MTDH-miRNA may play an important role in down-regulating proliferation, motility and migration in breast cancer cells, and should be considered as a potential small molecule inhibitor therapeutic targeting strategy for the future.


  1. Brown DM, Ruoslahti E (2004). Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell, 5, 365-74.
  2. Boudreau RL, Martins I, Davidson BL et al (2009). Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther, 17, 169-75.
  3. Calin GA, Sevignani C, Dumitru CD, et al (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A, 101, 2999-3004.
  4. Chen D, Yoo BK, Santhekadur PK, et al (2011). Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma. Clin Cancer Res, 17, 6693-701.
  5. Hui AB, Bruce JP, Alajez NM, et al (2011). Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res, 17, 7539-50.
  6. Hu G, Chong RA, Yang Q, et al (2009). MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell, 15, 9-20.
  7. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 134.
  8. Jian-bo X, Hui W, Yu-long H, et al (2011). Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol, 28, 455-62.
  9. Kang DC, Su ZZ, Sarkar D, et al (2005). Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene, 353, 8-15.
  10. Kikuno N, Shiina H, Urakami S, et al (2007). Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene, 26, 7647-55.
  11. Lee SG, Su ZZ, Emdad L, et al (2008). Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene, 27, 1114-21.
  12. Li C, Liu J, Lu R, et al (2011). AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Int J Gynecol Cancer, 21, 602-8.
  13. Li J, Yang L, Song L, et al (2009). Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene, 28, 3188-96.
  14. Li J, Zhang N, Song LB, et al (2008). Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res, 14, 3319-26.
  15. Li X, Kong X, Huo Q, et al (2011). Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci, 102, 1151-7.
  16. McBride JL, Boudreau RL, Harper SQ, et al (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A, 105, 5868-73.
  17. Nohata N, Hanazawa T, Kikkawa N, et al (2011). Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet, 56, 595-601.
  18. Sarkar D, Park ES, Emdad L, et al (2008). Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res, 68, 1478-84.
  19. SinghS, NarangAS, MahatoRI (2011). Subcellular fate and offtarget effects of siRNA, shRNA, and miRNA. Pharm Res, 28, 2996-3015.
  20. Song H, Li C, Li R, Geng J (2010). Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis, 25, 1201-9.
  21. Song H, Li C, Lu R, Zhang Y, Geng J (2010). Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Int J Gynecol Cancer, 20, 1188-96.
  22. Wang Z, Rao DD, Senzer N, Nemunaitis J (2011). RNA interference and cancer therapy. Pharm Res, 28, 2983-95.
  23. Yoo BK, Emdad L, Su ZZ, et al (2009). Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest, 119, 465-77.
  24. Zhao Y, Kong X, Li X, et al (2011). Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One, 6, e29363.

Cited by

  1. Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin vol.10, pp.5, 2015,
  2. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation vol.282, pp.20, 2015,
  3. MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro vol.5, pp.1, 2016,
  4. miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2 vol.37, pp.5, 2017,
  5. Progress of cancer research on astrocyte elevated gene-1/Metadherin (Review) vol.8, pp.2, 2014,